Efficacy and Tolerability of Ublituximab after Transitioning from a Different Disease-Modifying Therapy: Updates from the ENHANCE Study

site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
vertical-expand: a:0:{}
caf_enhance: 0
Drug Category: Array
Conference Category: Array
Lead Author: J Foley, et al.
Published Date: 18/09/2024
Download Link: /wp-content/uploads/2024/09/Foley_ENHANCE_P329_ECTRIMS_2024-FINAL.pdf
Download Text:
Popup Confirmation?:
astra-migrate-meta-layouts: set
Scroll to Top